20-31861452-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_080611.5(DUSP15):āc.659A>Cā(p.Gln220Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,557,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_080611.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUSP15 | NM_080611.5 | c.659A>C | p.Gln220Pro | missense_variant | 7/7 | ENST00000339738.10 | NP_542178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUSP15 | ENST00000339738.10 | c.659A>C | p.Gln220Pro | missense_variant | 7/7 | 1 | NM_080611.5 | ENSP00000341658.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000544 AC: 9AN: 165308Hom.: 0 AF XY: 0.0000651 AC XY: 6AN XY: 92184
GnomAD4 exome AF: 0.0000178 AC: 25AN: 1405736Hom.: 0 Cov.: 39 AF XY: 0.0000187 AC XY: 13AN XY: 697006
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.659A>C (p.Q220P) alteration is located in exon 7 (coding exon 7) of the DUSP15 gene. This alteration results from a A to C substitution at nucleotide position 659, causing the glutamine (Q) at amino acid position 220 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at